Evotec SEEVO
Price as of · delayed, not real-time
A contract development and manufacturing organization (CDMO) and drug discovery partner based in Germany, serving pharmaceutical and biotech clients across the globe. The company provides integrated services from target identification through clinical and commercial manufacturing, with a focus on small molecules and biologics. Investors track Evotec for its long-term partnership agreements and its exposure to the outsourced drug development market.
Congressional Interest in Evotec SE (EVO)
1 member of Congress has disclosed 1 trade in Evotec SE (EVO), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Who in Congress Is Trading EVO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-06-06 | Diana Harshbarger | sell | $15K-$50K |